Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to assess the safety profile of bevacizumab when combined with taxane monotherapy or in combination as first line treatment of patients with locally recurrent (LR) or metastatic breast cancer (mBC).
Critère d'inclusion
- Locally Recurrent or Metastatic Breast Cancer